Episode

CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson

Podcast
Hematologic Oncology Update
Published
Apr 10, 2026
Duration seconds
1494
Processing state
not_requested
Canonical source
https://hematologic-oncology.captivate.fm/episode/5876-insidetheissue2025-celmodsmrdmm-micro2
Audio
https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/5cfa91e0-78c1-4841-86dd-cc1394553c56.mp3
JSON
/v1/public/podcasts/hematologic-oncology-update-916423/episodes/celmods-for-multiple-myeloma-microlearning-activity-2-with-dr-paul-g-richardson
Markdown
/podcast/hematologic-oncology-update-916423/celmods-for-multiple-myeloma-microlearning-activity-2-with-dr-paul-g-richardson.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/celmods-for-multiple-myeloma-microlearning-activity-2-with-dr-paul-g-richardson/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/hematologic-oncology-update-916423/celmods-for-multiple-myeloma-microlearning-activity-2-with-dr-paul-g-richardson.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma. CME information and select publications here .